PF-Atlas › Clinical Trials › NCT00450073

Improving Vitamin D Status In Cystic Fibrosis

ergocalciferol · Not specified

Registry ID
NCT00450073
Phase
Not specified
Status
Completed
Drug / intervention
ergocalciferol (vitamin D2)
Sponsor
Atlanta VA Medical Center
Start
2006-11
Enrollment
30
Locations
1

About this trial

The purpose of this study is to establish an effective method to correct vitamin D deficiency in subjects with cystic fibrosis. The investigators will examine cholecalciferol, ergocalciferol and UV light.

View NCT00450073 on ClinicalTrials.gov →

Explore related

All ergocalciferol trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT00450073 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.